Private Equity
Xbrane Biopharma delivers first batch of Spherotide.
27 mars, 2017
Xbrane Biopharma has delivered its first batch of Spherotide to its partner in the Middle East to a value of 7 MSEK. Xbrane expects shipment of at least two additional batches of similar size to its partner in the Middle East during 2017.
Private Equity
OrganoClicks subsidiary BIOkleen signs general agreement with Granngården
24 mars, 2017
OrganoClicks subsidiary, BIOkleen Miljökemi AB, sells and markets cleaning and maintenance products for wood, home, house, and automotive. BIOkleen’s products are available both at paint dealers, DIYs and building supply stores...
Private Equity
Zenterio Reports Fourth Quarter
14 mars, 2017
The fourth quarter has again been a busy one. Our greatest challenge in this quarter has been the large number of software releases for our main customers. We have now delivered more than 10 major software releases to the Deutsche Telekom Group.
Private Equity
Zenterio shows seamless multiscreen TV integration at CABSAT 2017
8 mars, 2017
Zenterio, a leading television and multiscreen solutions provider, will showcase its technology portfolio for TV operators at CABSAT in Dubai, on March 21-23, 2017.
Private Equity
Xbrane Biopharma reports positive in-vitro biosimilarity data on Xlucane
27 februari, 2017
Xbrane Biopharma has performed a comprehensive in-vitro biosimilarity study with several pilot scale R&D batches of Xlucane versus several batches of the reference product.
